Algeria vs Libya: Antiretroviral therapy coverage for PMTCT
Algeria
74.0%
in 2019
Libya
70.0%
in 2023
Algeria rank
48th
Libya rank
51st
Antiretroviral therapy coverage for PMTCT over time
- Algeria
- Libya
How they compare
Algeria currently reports 74.0% against 70.0% in Libya, a difference of 4.0%.
That makes Algeria's figure about 1.1 times Libya's.
The two have swapped places 3 times across 14 shared years of data; in 2000 it was Libya ahead.
Algeria ranks 48th and Libya ranks 51st of 84 countries.
Across the 2 decades both report, Algeria averaged higher in 1 and Libya in 1.
Head to head by decade
| Decade | Algeria | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 0.0% | 6.9% | Algeria |
| 2010s | 63.5% | 65.8% | 2.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Algeria or Libya?
- Algeria, at 74.0% against 70.0% in Libya as of 2019.
- What is the difference in antiretroviral therapy coverage for pmtct between Algeria and Libya?
- 4.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Libya?
- 14 years are reported by both, from 2000 to 2019.
- How do Algeria and Libya rank globally for antiretroviral therapy coverage for pmtct?
- Algeria ranks 48th and Libya ranks 51st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).